Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers


  Free Subscription


2 Diabetes Care
1 Eur J Endocrinol
3 N Engl J Med
1 Nutr Rev
6 Obes Surg
8 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. TOUVIER M, da Costa Louzada ML, Mozaffarian D, Baker P, et al
    Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait.
    BMJ. 2023;383:e075294.
    PubMed         Abstract available

  2. GHOSH TS, Valdes AM
    Evidence for clinical interventions targeting the gut microbiome in cardiometabolic disease.
    BMJ. 2023;383:e075180.
    PubMed         Abstract available

  3. MAESSEN SE, Nichols M, Cutfield W, Norris SA, et al
    High but decreasing prevalence of overweight in preschool children: encouragement for further action.
    BMJ. 2023;383:e075736.
    PubMed         Abstract available

    Diabetes Care

  4. OTT R, Stein R, Hauta-Alus HH, Ronkainen J, et al
    Epigenome-Wide Meta-analysis Reveals Associations Between Dietary Glycemic Index and Glycemic Load and DNA Methylation in Children and Adolescents of Different Body Sizes.
    Diabetes Care. 2023;46:2067-2075.
    PubMed         Abstract available

  5. ZACCARDI F, Ling S, Brown K, Davies M, et al
    Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England.
    Diabetes Care. 2023 Aug 28:dc231013. doi: 10.2337/dc23-1013.
    PubMed         Abstract available

    Eur J Endocrinol

  6. GATTA-CHERIFI B, Laboye A, Gronnier C, Monsaingeon-Henry M, et al
    A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.
    Eur J Endocrinol. 2023;189:K15-K18.
    PubMed         Abstract available

    N Engl J Med

  7. JASTREBOFF AM, Kaplan LM, Hartman ML
    Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.
    N Engl J Med. 2023;389:1629-1630.

  8. ELFEKI MA, Alkhouri N
    Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
    N Engl J Med. 2023;389:1629.

  9. BISSON A, Fauchier G, Fauchier L
    Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
    N Engl J Med. 2023;389:1628.

    Nutr Rev

  10. DUARTE CK, de Abreu Silva L, Castro CF, Ribeiro MV, et al
    Prediction equations to estimate muscle mass using anthropometric data: a systematic review.
    Nutr Rev. 2023;81:1414-1440.
    PubMed         Abstract available

    Obes Surg

  11. DIAB AF, Sher T, Awshah S, Noom M, et al
    Reply to Letter to the Editor: Oversewing/Suturing of the Staple Line During Sleeve Gastrectomy Is an Effective and Affordable Staple Line Reinforcement Method: a Meta-analysis of Randomized Controlled Trials.
    Obes Surg. 2023;33:3672-3673.

  12. HOAGLAND D, Olasky J, Kent TS, Vosburg RW, et al
    The Impact of Trainee Involvement on Outcomes in Metabolic and Bariatric Surgery.
    Obes Surg. 2023;33:3454-3462.
    PubMed         Abstract available

  13. BARTHOLOMAY EM, Cox S, Tabone L, Szoka N, et al
    Intrapersonal coping predicts greater weight loss 24 months after bariatric surgery.
    Obes Surg. 2023;33:3447-3453.
    PubMed         Abstract available

  14. PEREIRA JPS, Calafatti M, Martinino A, Ramnarain D, et al
    Epicardial Adipose Tissue Changes After Bariatric and Metabolic Surgery: a Systematic Review and Meta-analysis.
    Obes Surg. 2023;33:3636-3648.
    PubMed         Abstract available

  15. YANG JC, Zhang GX, Leng C, Chen G, et al
    Incidence and Intensity of Early Dumping Syndrome and Its Association with Health-Related Quality of Life Following Sleeve Gastrectomy.
    Obes Surg. 2023;33:3510-3516.
    PubMed         Abstract available

  16. DE LUCA M, Zese M, Silverii GA, Ragghianti B, et al
    Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events.
    Obes Surg. 2023 Nov 2. doi: 10.1007/s11695-023-06909.
    PubMed         Abstract available

    PLoS One

  17. RESTREPO-MESA SL, Benjumea Rincon MV, Estrada Restrepo A, Bousquet Carrilho TR, et al
    Gestational weight gain charts for Latin American adolescents.
    PLoS One. 2023;18:e0292070.
    PubMed         Abstract available

  18. HUANG B, DePaolo J, Judy RL, Shakt G, et al
    Relationships between body fat distribution and metabolic syndrome traits and outcomes: A mendelian randomization study.
    PLoS One. 2023;18:e0293017.
    PubMed         Abstract available

  19. CHEIKH ISMAIL L, Kassem H, Osaili TM, Hashim M, et al
    Public's calorie literacy and perceived effectiveness of restaurant menu calorie labeling in the United Arab Emirates.
    PLoS One. 2023;18:e0293387.
    PubMed         Abstract available

  20. SAID FA, Khamis AG, Salmin AH, Msellem SN, et al
    Influence of diet quality on nutritional status of school-aged children and adolescents in Zanzibar, Tanzania.
    PLoS One. 2023;18:e0293316.
    PubMed         Abstract available

  21. WARD AB, Harris PA, Argo CM, Watson CA, et al
    Confidence does not mediate a relationship between owner experience and likelihood of using weight management approaches for native ponies.
    PLoS One. 2023;18:e0292886.
    PubMed         Abstract available

  22. MUKADAM N, Marston L, Lewis G, Mathur R, et al
    South Asian, Black and White ethnicity and the effect of potentially modifiable risk factors for dementia: A study in English electronic health records.
    PLoS One. 2023;18:e0289893.
    PubMed         Abstract available

  23. MOTUMA A, Shiferaw K, Gobena T, Teji Roba K, et al
    Dyslipidemia and its predictors among adult workers in eastern Ethiopia: An institution-based cross-sectional study.
    PLoS One. 2023;18:e0291665.
    PubMed         Abstract available

  24. TESOLATO S, Ortega-Hernandez A, Gomez-Garre D, Claver P, et al
    Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.
    PLoS One. 2023;18:e0292551.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.